港股異動 | 華晨中國(1114.HK)漲超4% 華晨寶馬Q2業績增長強勁
格隆匯8月6日丨華晨中國(1114.HK)現報8.42港元,漲4.21%,暫成交2.3億港元,最新總市值424億港元。華晨中國合資公司華晨寶馬第二季度淨利潤按年勁升92%。花旗最新發研報指,上調華晨中國目標價15%至11.4港元,主要因為華晨寶馬第二季度淨利潤超出預期,估計短期豪華車銷量優於行業整體,對公司前景更加樂觀。該行將華晨寶馬2020年和2021年銷量預期上調3.6%和9.5%。此外,美銀證券亦指,因高檔汽車在疫情後的銷售及需求較大眾市場市場更具韌性,華晨寶馬在今年第二季的銷量按年增長30%。上調華晨中國目標價至10.1港元,評級“買入”。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.